Apogee Technology Confirms That It Will Submit a Listing Plan to American Stock Exchange

  
    
  
  
    
      As a result of multiple stockholder inquiries, Apogee Technology, Inc 
      (AMEX: ATA) confirmed today that it will issue a formal plan to the 
      American Stock Exchange before December 1, 2006 to pursue full 
      compliance with Sections 1003 (a) (ii) and (iii) for continued listing 
      on the American Stock Exchange. During this time, Apogee will continue 
      to operate in the ordinary manner and attend to its business objectives.
    
    
      About Apogee Technology, Inc.
    
    
      Apogee Technology designs, develops and commercializes proprietary 
      medical device and sensor products using its micro-systems and 
      nanotechnology for the medical, automotive, industrial and consumer 
      markets. The Company is developing its PyraDerm™ 
      solution for enhanced intradermal drug delivery and has introduced a 
      family of pressure sensors under the Sensilica™ 
      brand. Apogee’s goal is to provide value-added 
      and cost-savings solutions for our customers and, in so doing, to become 
      a global leader in the sensor and medical device fields. For more 
      information please visit our web site at: http://www.apogeemems.com.
    
    
      PyraDerm™ and Sensilica™ 
      are trademarks of Apogee Technology, Inc. All other product names noted 
      herein may be trademarks of their respective holders. Certain statements 
      made herein that use the words "anticipate," "hope," "estimate," 
      "project," "intend," "plan," "expect," "believe" and similar expressions 
      are intended to identify forward-looking statements within the meaning 
      of the Private Securities Litigation Reform Act of 1995. These 
      forward-looking statements involve known and unknown risks and 
      uncertainties, which could cause the actual results, performance or 
      achievements of the Company to be materially different from those that 
      may be expressed or implied. Please refer to the company's risk factors 
      as set forth in the Company's filings with the Securities and Exchange 
      Commission, including its reports on Forms 10-KSB and 10-QSB.
    
  
As a result of multiple stockholder inquiries, Apogee Technology,
Inc (AMEX: ATA) confirmed today that it will issue a formal plan to
the American Stock Exchange before December 1, 2006 to pursue full
compliance with Sections 1003 (a) (ii) and (iii) for continued listing
on the American Stock Exchange. During this time, Apogee will continue
to operate in the ordinary manner and attend to its business
objectives.

   About Apogee Technology, Inc.

   Apogee Technology designs, develops and commercializes proprietary
medical device and sensor products using its micro-systems and
nanotechnology for the medical, automotive, industrial and consumer
markets. The Company is developing its PyraDerm(TM) solution for
enhanced intradermal drug delivery and has introduced a family of
pressure sensors under the Sensilica(TM) brand. Apogee's goal is to
provide value-added and cost-savings solutions for our customers and,
in so doing, to become a global leader in the sensor and medical
device fields. For more information please visit our web site at:
http://www.apogeemems.com.

   PyraDerm(TM) and Sensilica(TM) are trademarks of Apogee
Technology, Inc. All other product names noted herein may be
trademarks of their respective holders. Certain statements made herein
that use the words "anticipate," "hope," "estimate," "project,"
"intend," "plan," "expect," "believe" and similar expressions are
intended to identify forward-looking statements within the meaning of
the Private Securities Litigation Reform Act of 1995. These
forward-looking statements involve known and unknown risks and
uncertainties, which could cause the actual results, performance or
achievements of the Company to be materially different from those that
may be expressed or implied. Please refer to the company's risk
factors as set forth in the Company's filings with the Securities and
Exchange Commission, including its reports on Forms 10-KSB and 10-QSB.